AVIR Atea Pharmaceuticals, Inc. Common Stock PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

Atea Pharmaceuticals (AVIR) Stock: Buy, Sell, or Hold?

$4.21
-0.01 (-0.24%) ▼
5d: -0.24% 30d: -9.07% 90d: -17.77%
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (86%)
Quality Score
55/100
Position
SLIGHTLY LOW
30-Day Fair Range
$4.09 – $4.83
Position: SLIGHTLY LOW
Forward P/E & Valuation
-2.8x
Next 12M consensus est.
Wall Street Target
$8.50
+101.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$3.95 / $4.50
Trend: Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: AVIR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.

Get Alerted When AVIR Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: AVIR is currently trading at $4.21, which is considered slightly low relative to its 30-day fair value range of $4.09 to $4.83.

Technical Outlook: Technically, AVIR is in a downtrend. Immediate support is located at $3.94, while resistance sits at $4.50.

Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $8.50 (+101.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position SLIGHTLY LOW
Historical Trading Range $4.09 - $4.83
Company Quality Score 55/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 86.2%

Trading Range & Key Levels

30-Day Trading Range $4.09 - $4.83
Current vs Trading Range SLIGHTLY LOW
Expected Move (7 Days) ±$0.53 (12.6%)
Support Level $3.95
Resistance Level $4.50
Current Trend Downtrend
Technical data as of Nov 12, 2026

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Options cheap (IV 0th percentile)
  • NEUTRAL: Mixed technical signals (55/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 101.9% below Wall St target ($8.50)
  • NEUTRAL: Bottoming setup forming (55/100) — watch for confirmation

Fundamental Context

Forward P/E (Next Year Est.) -2.84
Wall Street Target $8.50 (+101.9%)
Revenue Growth (YoY) 295.2%
Earnings Growth (YoY) 264.1%
Share AVIR Analysis

Share this live AVIR analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (AVIR)

Bullish 3 Retail Mentions
Reddit / WSB Comments
2
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Aug 10, 2026
Daily AI digest
AI Retail Discussion Summary: A bullish StockTwits message suggests buying $AVIR due to its net cash value of $6.50 per share, with no recent negative news reported.
Key Retail Themes: Net cash value
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:03 AM ET
Data refreshes hourly during market hours. Next update: 6:03 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for AVIR.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
CYTK
Cytokinetics Inc
STRONG BUY
22 analysts
$107 65 BUY
INSM
Insmed Inc
STRONG BUY
24 analysts
$194 37 SELL
MDGL
Madrigal Pharmaceuticals…
STRONG BUY
19 analysts
$689 58 HOLD
CRNX
Crinetics Pharmaceutical…
STRONG BUY
17 analysts
$86 46 HOLD
IMNM
Immunome Inc
STRONG BUY
17 analysts
$35 46 HOLD

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive AVIR Research Pages
AVIR Technical Chart AVIR Price Prediction AVIR Intrinsic Value DCF AVIR Earnings Date AVIR Investment Advisor AVIR Fair Price Analyzer AVIR Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals